FDA Approves Zeposia (Ozanimod), Oral Th... - My MSAA Community

My MSAA Community

9,335 members21,075 posts

FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS

bxrmom profile image
3 Replies

“With the FDA approval of Zeposia, appropriate patients with relapsing forms of multiple sclerosis will have another oral treatment option with meaningful efficacy to help address the disease’s hallmark relapses and brain lesions,” said Samit Hirawat, MD, the company’s chief medical officer.

multiplesclerosisnewstoday....

Written by
bxrmom profile image
bxrmom
To view profiles and participate in discussions please or .
3 Replies
DM0329 profile image
DM0329

Thanks for sharing this information! :)

bxrmom profile image
bxrmom in reply to DM0329

Of course! I love to share when I find out new info about MS and ways to treat it :) Have a great day!

greaterexp profile image
greaterexp

Let’s hope it works well!

Not what you're looking for?

You may also like...

First Oral CGRP for Migraine – Ubrelvy – is Approved by FDA

I just received an alert about Ubrelvy getting approved for migraines. Looking forward to hearing...

Ocrevus: FDA Approves First Drug to Treat Two Forms of MS

Here is an excerpt from MSAA's article on the latest MS treatment news: "On March 28, 2017, the...

MS Treatment

I have been on Tysabri and will be changing medication. My Dr suggested either Mavenclad or...

Pulse therapy for MS

My wife was diagnosed with MS in July this year. Following a 5-day corticosteroid pulse therapy...

Dealing with MS for 25+ years

Hello to everyone! I've had had MS for 29 years. I just like to know tsome people are doing with...